# Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/risankizumab-versus-ustekinumab-for-moderate-to-severe-plaque-psoriasis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kim Papp,Andrew Blauvelt,Michael Bukhalo,Melinda Gooderham,James G. Krueger,J.‐P. Lacour,Alan Menter,Sandra Philipp,Howard Sofen,Stephen K. Tyring,B Berner,Sudha Visvanathan,Chandrasena Pamulapati,Nathan Bennett,Mary Flack,Paul Scholl,Steven J. Padula |
| Citations | 514 |
| DOI | 10.1056/nejmoa1607017 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1607017?articleTools=true |
| OpenAlex ID | https://openalex.org/W2606035821 |
| PMID | 28423301 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Melinda Gooderham](https://scholariq.org/researchers/melinda-gooderham/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Hidradenitis Suppurativa and Treatments](https://scholariq.org/topics/hidradenitis-suppurativa-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.